Alonzo is the current Manager of HR and Operations for LifeSci Partners. He brings a wealth of administrative, logistical and leadership expertise to the firm, after having over 15 years of support experience with both internal and external clients at Clear Channel/iHeart Media, Angelo, Gordon & Co., and Citigroup. Known as the “Concierge”, Alonzo is responsible for daily office management operations, assisting in Diversity and Inclusion initiatives, onboarding both new clients and employees, and basically just getting “IT” done. He is a native of Nashville, TN and now resides in NYC as guardian to his dog and cat.

Michal Fisher has a decade of business experience, including executive positions in the life sciences sector directing business, corporate development and strategy. Prior to joining LifeSci, Michal managed business development and licensing activities across multiple therapeutic areas at Neopharm. Prior to Neopharm, Michal was Head of Strategic Alliances at SK Pharma, where she led multiple transactions and executed company growth initiatives.

Michal received an MA in Law and a BSc in Biotechnology from Bar-Ilan University.

Chris has spent his career in biopharmaceutical strategy consulting.  His work includes commercial due diligence, asset valuation, commercial launch strategy, and portfolio strategy across numerous therapeutic areas.

Prior to LifeSci, Chris was a Consultant at Trinity, a life science strategy consulting firm.  He received a B.A. in Economics from Middlebury College.

Before joining LifeSci, David worked at PRECISIONadvisors (formerly Insight Strategy Advisors), a leading pricing and market access life sciences consulting firm. He has worked with Fortune 100 pharmaceutical companies, clinical-stage biotech companies, and digital health companies. His therapeutic area experience includes but is not limited to rare diseases, NASH, oncology, asthma, COPD, and diabetes.

David graduated from Brandeis University with a B.S. in Biology and Public Health.

Sarah has spent her career supporting informed strategic decision-making across the biopharmaceutical industry. Her work has spanned due diligence, strategic partnering and fundraising, drug and franchise strategy, pricing and market access, and overall corporate and business development strategy for biotech and pharmaceutical clients.

Prior to LifeSci, Sarah was a consultant with ClearView Healthcare Partners, a strategy consulting firm in the life sciences. She studied Human Developmental and Regenerative Biology with a minor in Mind, Brain and Behavior at Harvard University and researched the behavior of stem cells in the skin in the Hsu Lab.

Mike joined the Partnering and Analytics team as an Analyst in November 2019. Mike obtained a B.A. in Economics from the College of the Holy Cross in May 2019. At Holy Cross, Mike was a member of the Men’s Ice Hockey Team for four years and served as the team captain his junior and senior year.

Owen has experience in business development, strategy consulting and conducting market research to inform strategic decision-making in a variety of therapeutic areas. Prior to joining LifeSci, Owen worked at TRINITY Life Sciences within the Strategic Advisory arm of the firm supporting project research and material development.

He holds a B.S. in Biological Sciences concentrating in Computational Biology / Biochemistry, and a Masters in Computing and Information Science from Cornell University. During his time at Cornell, Owen conducted research in quantitative biology, astrobiology, and astrophysics.

Joe joined the Partnering & Analytics team as a Senior Analyst in March 2021. Prior to joining LifeSci, he was a Partnerships Lead at a biomedical AI firm (“nference”), where he leveraged analytical tools for drug discovery and built strategic partnerships with pharma companies. Prior to nference, he was a Venture Fellow at Spartan Innovations, where he developed commercialization strategies for university technologies, including a gene therapy platform for CNS therapeutics.

He holds a PhD in Biomedical Engineering and a BS in Neuroscience through a fast-track BS/PhD program at Michigan State University. His doctoral research developed genetic and electrophysiological techniques to improve the use of microelectrode arrays implanted in the brain. His PhD produced 10+ scientific publications.

Sasmita completed her B.S. in Biological Sciences from Purdue University and Masters in Bioengineering from University of Pennsylvania. Prior to joining LifeSci she worked for Axiom Healthcare Strategies, an oncology- and rare disease-focused consulting firm, supporting multiple projects in the breast and gynecological cancer spaces.

During her time at UPenn, she was actively involved in computational biology research as a Data Analyst at Penn Medicine and served on the board for the Penn Graduate Consulting Club.

Isaac holds a B.A. in Economics from Cornell University and completed the pre-medicine track. He proceeded to gain an M.S. in Biotechnology from the University of Pennsylvania where he focused on cancer biology and immunology.

Prior to joining LifeSci, Isaac worked at the Center for Cellular Immunotherapies (CCI) at the University of Pennsylvania where he conducted lab research on novel CAR-T therapies. He was also a member of Wharton’s Penn Biotech Group (PBG), which consults with clients in the life sciences space.

Vanessa joined the Partnering & Analytics team as an Analyst in April 2021. Prior to joining LifeSci, Vanessa worked at Yale Center for Clinical Investigation supporting clinical research related to COVID-19.

She graduated from Yale University with a B.A. in History of Science, Medicine, and Public Health and completed the pre-medicine track. During her time at Yale, she conducted research in the Chun Lab at the Yale Cardiovascular Research Center, served as captain of the Women’s Varsity Lacrosse Team, and volunteered for a non-profit organization called Camp Kesem.

Ayal joined the Partnering and Analytics team as an Analyst Advisor based out of the Israel office.  Prior to joining, he founded an organization to ensure ethical treatment and safety within numerous at-risk industries.

Concurrent to his role, Ayal is completing a B.Sc. in Computer Science.